GGrantIndex
← Search

IS LACTATE DEHYDROGENASE-A (LDH-A) A VIABLE TARGET FOR PROSTATE CANCER THERAPY?

$391,109FY2010Department of DefenseDOD

Beth Israel Deaconess Medical Center, Inc.

Investigators

View source on USAspending →
IS LACTATE DEHYDROGENASE-A (LDH-A) A VIABLE TARGET FOR PROSTATE CANCER THERAPY? · GrantIndex